A pilot study for safety and efficacy of 12 weeks sofosbuvir plus daclatasvir with or without ribavirin in egyptian adolescents with chronic hepatitis C virus Infection

2017 ◽  
Vol 66 (1) ◽  
pp. S178 ◽  
Author(s):  
M. El-Sayed ◽  
M. Hassany ◽  
N. Asem
Sign in / Sign up

Export Citation Format

Share Document